Ontario: UCB's Prescription for Success
Location Canada 2009
In 2006, UCB Pharma Canada was established in Burlington, Ontario, to bring new and improved biopharmaceutical treatment options to Canadian patients who suffer from often-debilitating conditions. Expanding overseas was an important step for UCB in furthering its work in research and the development of treatments. To support such expansion, UCB needed greater access to a skilled work force in the life sciences, opportunities to conduct high-quality clinical trials, as well as access to partnerships with suppliers and other businesses.
The company chose Ontario as its Canadian site for several reasons, including access to reputable business partners within the Greater Toronto area; its proximity to UCB's operations in Rochester, New York; and access to skilled medical researchers. Rob Hamilton, general Manager of UCB Pharma Canada, says "A skilled work force was an important factor. We've had no problem finding people" in Ontario.
Project Announcements
Groupe Touchette Expands Rosser, Manitoba, Operations
01/26/2024
Dana Canada Corporation Expands Oakville-Cambridge, Ontario, Canada, Operations
12/04/2023
E-One Moli Plans Maple Ridge, British Columbia, Manufacturing Operations
11/21/2023
Sweden-Based Northvolt Plans Quebec, Canada, Lithium Battery Gigafactory
10/02/2023
Martin Brower Plans Oshawa, Ontario, Canada, Distribution Hub
09/26/2023
Axium Packaging Plans Brampton, Ontario, Canada, Operations
09/05/2023
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024